Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
04 2019
Historique:
received: 11 12 2018
accepted: 12 01 2019
pubmed: 27 1 2019
medline: 17 3 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

The treatment of ruptured posterior circulation aneurysms remains challenging despite progresses in the endovascular and neurosurgical techniques. To provide epidemiological characterization of subjects presenting with ruptured posterior circulation aneurysms in Switzerland and thereby assessing the treatment patterns and neurological outcomes. This is a retrospective analysis of the Swiss SOS registry for patients with aneurysmal subarachnoid hemorrhage. Patients were divided in 3 groups (upper, lower, and middle third) according to aneurysm location. Clinical, radiological, and treatment-related variables were identified and their impact on the neurological outcome was determined. From 2009 to 2014, we included 264 patients with ruptured posterior circulation aneurysms. Endovascular occlusion was the most common treatment in all 3 groups (72% in the upper third, 68% in the middle third, and 58.8% in the lower third). Surgical treatment was performed in 11.3%. Favorable outcome (mRS ≤ 3) was found in 56% at discharge and 65.7% at 1 year. No significant difference in the neurological outcome were found among the three groups, in terms of mRS at discharge (p = 0.20) and at 1 year (p = 0.18). High WFNS grade, high Fisher grade at presentation, and rebleeding before aneurysm occlusion (p = 0.001) were all correlated with the risk of unfavorable neurological outcome (or death) at discharge and at 1 year. In this study, endovascular occlusion was the principal treatment, with a favorable outcome for two-thirds of patients at discharge and at long term. These results are similar to high volume neurovascular centers worldwide, reflecting the importance of centralized care at specialized neurovascular centers.

Sections du résumé

BACKGROUND
The treatment of ruptured posterior circulation aneurysms remains challenging despite progresses in the endovascular and neurosurgical techniques.
OBJECTIVE
To provide epidemiological characterization of subjects presenting with ruptured posterior circulation aneurysms in Switzerland and thereby assessing the treatment patterns and neurological outcomes.
METHODS
This is a retrospective analysis of the Swiss SOS registry for patients with aneurysmal subarachnoid hemorrhage. Patients were divided in 3 groups (upper, lower, and middle third) according to aneurysm location. Clinical, radiological, and treatment-related variables were identified and their impact on the neurological outcome was determined.
RESULTS
From 2009 to 2014, we included 264 patients with ruptured posterior circulation aneurysms. Endovascular occlusion was the most common treatment in all 3 groups (72% in the upper third, 68% in the middle third, and 58.8% in the lower third). Surgical treatment was performed in 11.3%. Favorable outcome (mRS ≤ 3) was found in 56% at discharge and 65.7% at 1 year. No significant difference in the neurological outcome were found among the three groups, in terms of mRS at discharge (p = 0.20) and at 1 year (p = 0.18). High WFNS grade, high Fisher grade at presentation, and rebleeding before aneurysm occlusion (p = 0.001) were all correlated with the risk of unfavorable neurological outcome (or death) at discharge and at 1 year.
CONCLUSIONS
In this study, endovascular occlusion was the principal treatment, with a favorable outcome for two-thirds of patients at discharge and at long term. These results are similar to high volume neurovascular centers worldwide, reflecting the importance of centralized care at specialized neurovascular centers.

Identifiants

pubmed: 30680461
doi: 10.1007/s00701-019-03812-9
pii: 10.1007/s00701-019-03812-9
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-779

Investigateurs

Kulcsàr Zsolt (K)
Emanuela Keller (E)
Luca Regli (L)
Oliver Bozinov (O)
Sina Finkenstädt (S)
Daniel Schöni (D)
Andreas Raabe (A)
Jürgen Beck (J)
Johannes Goldberg (J)
Luigi Mariani (L)
Raphael Guzman (R)
Javier Fandino (J)
Daniel Coluccia (D)
Cianfoni Alessandro (C)
Daniele Valsecchi (D)
Alessio Chiappini (A)
Alice Venier (A)
Michael Reinert (M)
Johannes Weber (J)
Andrea Ferrari (A)
Astrid Weyerbrock (A)
Gerhard Hildebrandt (G)
Martin Hlavica (M)
Vitor Mendes Pereira (VM)
Marco Corniola (M)
Karl Schaller (K)

Commentaires et corrections

Type : ErratumIn

Auteurs

Rodolfo Maduri (R)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland. Rodolfo.maduri@gmail.com.

Daniele Starnoni (D)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.

Alda Rocca (A)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.

David Bervini (D)

Department of Neurosurgery, Inselspital, University of Bern, Bern, Switzerland.

Daniel Walter Zumofen (DW)

Department of Neurosurgery, Basel University Hospital, Basel, Switzerland.
Diagnostic and Interventional Neuroradiology Section, Department of Radiology, Basel University Hospital, Basel, Switzerland.

Martin Nikolaus Stienen (MN)

Department of Neurosurgery, University Hospital of Zurich & Clinical Neurosciences Center, University of Zurich, Zurich, Switzerland.

Bawarjan Schatlo (B)

Department of Neurosurgery, University Hospital Göttingen, Göttingen, Germany.

Christian Fung (C)

Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.

Thomas Robert (T)

Department of Neurosurgery, Ospedale Civico di Lugano, Lugano, Switzerland.

Martin A Seule (MA)

Department of Neurosurgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, University Hospital of Zurich & Clinical Neurosciences Center, University of Zurich, Zurich, Switzerland.
Department of Neurosurgery, Baylor Medical Center & College of Medicine, Houston, TX, USA.

Nicolai Maldaner (N)

Department of Neurosurgery, University Hospital of Zurich & Clinical Neurosciences Center, University of Zurich, Zurich, Switzerland.

Michel Rothlisberger (M)

Department of Neurosurgery, Basel University Hospital, Basel, Switzerland.

Kristine A Blackham (KA)

Diagnostic and Interventional Neuroradiology Section, Department of Radiology, Basel University Hospital, Basel, Switzerland.

Serge Marbacher (S)

Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Donato D'Alonzo (D)

Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Luca Remonda (L)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Kantonsspital Aarau, Aarau, Switzerland.

Paolo Machi (P)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Geneva University Hospital (HUG), Geneva, Switzerland.

Jan Gralla (J)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Bern, Switzerland.

Philippe Bijlenga (P)

Department of Neurosurgery, Hopitaux Universitaires Genève, Geneva, Switzerland.

Guillaume Saliou (G)

Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Pierluigi Ballabeni (P)

Lausanne Institute for Clinical Epidemiology and Biostatistics, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Marc Levivier (M)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Mahmoud Messerer (M)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Roy Thomas Daniel (RT)

Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
University of Lausanne (UniL), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH